Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ) SHZ
15.97
-0.12(-0.75%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
Address
Wuhan Optics Valley International Biomed
Wuhan, 430074
China
Phone
86 27 8700 1772
Sector
Healthcare
Industry
Medical - Devices
Employees
1063
First IPO Date
July 10, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Rui Wang | Deputy GM, Chief Financial Officer & Board Secretary | 0 | 1978 |
| Chaohui Li | Accounting Supervisor | 0 | N/A |
| Chen Li Li | Chairman & GM | 0 | 1974 |
| Wang Ying | Vice Chairman & Deputy GM | 0 | 1974 |
Description
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally. Its products portfolio includes molecular diagnostic products, such as drug metabolism genetic testing and pathogen nucleic acid detection kits; and immunodiagnostic and blood gas diagnosis products. The company also provides emergency and critical illness information solutions, including information software products, supporting hardware, and certification consulting services; and third-party medical inspection services. It offers products in the areas of cardiovascular, kidney, infectious, diabetes, endocrine and metabolic, obstetrics, and gynecology diseases, as well as prenatal and postnatal care, health checkups, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection. The company was founded in 2008 and is based in Wuhan, China.